Literature DB >> 11254534

Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury.

K Soejima1, L D Traber, F C Schmalstieg, H Hawkins, J M Jodoin, C Szabo, E Szabo, L Virag, A Salzman, D L Traber, L Varig.   

Abstract

Patients with severe burn and/or smoke inhalation injury suffer both systemic and pulmonary vascular hyperpermeability. We hypothesized that nitric oxide (NO) produced by inducible nitric oxide synthase (iNOS) plays a role in the changes in microvascular permeability seen with this injury. To test the hypothesis, we administered mercaptoethylguanidine (MEG), a selective iNOS inhibitor, to conscious sheep subjected to a combined smoke inhalation and third-degree burn injury to 40% of total body surface area. The sheep were surgically prepared for chronic study with lung and prefemoral lymph fistulas in order to estimate microvascular permeability. Both the groups and a control group of animals showed an increase in iNOS protein and message in their lungs. The control animals showed significant increases in either plasma or lymph NO2-/NO3- (NOx) concentration at 24 h after injury, with associated cardiac depression and hemoconcentration. The airway epithelium stained for nitrotyrosine. In the treatment group, NOx did not increase significantly in plasma or lymph throughout the experiment, there was no nitrotyrosine staining, hemodynamic depression was not observed, and the fluid requirement was significantly less than in the control group. Changes in pulmonary microvascular permeability were significantly suppressed by inhibition of iNOS. However, there was no significant difference between the two study groups in the microvascular permeability of burned tissue. These data suggest that NO produced by iNOS plays an important role in the changes in systemic and pulmonary microvascular permeability in combined smoke inhalation/third-degree burn injury, but does not affect the vascular permeability of third-degree-burned tissue in this type of injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254534     DOI: 10.1164/ajrccm.163.3.9912052

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  29 in total

1.  Beneficial pulmonary effects of a metalloporphyrinic peroxynitrite decomposition catalyst in burn and smoke inhalation injury.

Authors:  Matthias Lange; Csaba Szabo; Perenlei Enkhbaatar; Rhykka Connelly; Eszter Horvath; Atsumori Hamahata; Robert A Cox; Aimalohi Esechie; Yoshimitsu Nakano; Lillian D Traber; David N Herndon; Daniel L Traber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-12       Impact factor: 5.464

2.  Pulmonary microvascular hyperpermeability and expression of vascular endothelial growth factor in smoke inhalation- and pneumonia-induced acute lung injury.

Authors:  Matthias Lange; Atsumori Hamahata; Daniel L Traber; Rhykka Connelly; Yoshimitsu Nakano; Lillian D Traber; Frank C Schmalstieg; David N Herndon; Perenlei Enkhbaatar
Journal:  Burns       Date:  2012-05-29       Impact factor: 2.744

3.  Nebulization with γ-tocopherol ameliorates acute lung injury after burn and smoke inhalation in the ovine model.

Authors:  Yusuke Yamamoto; Perenlei Enkhbaatar; Linda E Sousse; Hiroyuki Sakurai; Sebastian W Rehberg; Sven Asmussen; Edward R Kraft; Charlotte L Wright; Eva Bartha; Robert A Cox; Hal K Hawkins; Lillian D Traber; Maret G Traber; Csaba Szabo; David N Herndon; Daniel L Traber
Journal:  Shock       Date:  2012-04       Impact factor: 3.454

4.  Blocking CXCL1-dependent neutrophil recruitment prevents immune damage and reduces pulmonary bacterial infection after inhalation injury.

Authors:  Julia L M Dunn; Laurel B Kartchner; Wesley H Stepp; Lindsey I Glenn; Madison M Malfitano; Samuel W Jones; Claire M Doerschuk; Robert Maile; Bruce A Cairns
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-25       Impact factor: 5.464

Review 5.  Gammadelta T-cells: potential regulators of the post-burn inflammatory response.

Authors:  Martin G Schwacha
Journal:  Burns       Date:  2008-10-31       Impact factor: 2.744

6.  Molecular biological effects of selective neuronal nitric oxide synthase inhibition in ovine lung injury.

Authors:  Fiona D Saunders; Martin Westphal; Perenlei Enkhbaatar; Jianpu Wang; Konrad Pazdrak; Yoshimitsu Nakano; Atsumori Hamahata; Collette C Jonkam; Matthias Lange; Rhykka L Connelly; Gabriela A Kulp; Robert A Cox; Hal K Hawkins; Frank C Schmalstieg; Eszter Horvath; Csaba Szabo; Lillian D Traber; Elbert Whorton; David N Herndon; Daniel L Traber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-04       Impact factor: 5.464

7.  Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury.

Authors:  Perenlei Enkhbaatar; Rhykka Connelly; Jianpu Wang; Yoshimitsu Nakano; Matthias Lange; Atsumori Hamahata; Eszter Horvath; Csaba Szabo; Stefan Jaroch; Peter Hölscher; Margrit Hillmann; Lillian D Traber; Frank C Schmalstieg; David N Herndon; Daniel L Traber
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

8.  Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury.

Authors:  Matthias Lange; Rhykka Connelly; Daniel L Traber; Atsumori Hamahata; Robert A Cox; Yoshimitsu Nakano; Kamna Bansal; Aimalohi Esechie; Sanna von Borzyskowski; Collette Jonkam; Lillian D Traber; Hal K Hawkins; David N Herndon; Perenlei Enkhbaatar
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

Review 9.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

Review 10.  Bench-to-bedside review: Burn-induced cerebral inflammation--a neglected entity?

Authors:  Michael A Flierl; Philip F Stahel; Basel M Touban; Kathryn M Beauchamp; Steven J Morgan; Wade R Smith; Kyros R Ipaktchi
Journal:  Crit Care       Date:  2009-06-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.